Joel Wight

481 total citations
22 papers, 157 citations indexed

About

Joel Wight is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Joel Wight has authored 22 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 13 papers in Genetics and 9 papers in Oncology. Recurrent topics in Joel Wight's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Joel Wight is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Joel Wight collaborates with scholars based in Australia and United Kingdom. Joel Wight's co-authors include Eliza A. Hawkes, Andrew Grigg, Geoffrey Chong, Matthew Ku, Colm Keane, Piers Blombery, Jason A. Trubiano, Masa Lasica, Michael Dickinson and Leonid Churilov and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Joel Wight

18 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Wight Australia 8 104 58 43 43 24 22 157
Michela Ansuinelli Italy 6 89 0.9× 63 1.1× 24 0.6× 42 1.0× 20 0.8× 13 140
Jesse Shustik Canada 5 114 1.1× 78 1.3× 50 1.2× 27 0.6× 26 1.1× 11 142
Yazeed Sawalha United States 8 99 1.0× 97 1.7× 53 1.2× 18 0.4× 24 1.0× 43 169
Anupkumar George Australia 4 100 1.0× 65 1.1× 54 1.3× 42 1.0× 19 0.8× 6 143
Susana Ben Neriah Canada 4 134 1.3× 80 1.4× 65 1.5× 44 1.0× 18 0.8× 5 158
Agnieszka Giza Poland 8 121 1.2× 84 1.4× 37 0.9× 35 0.8× 22 0.9× 40 177
Kerstin Busch Germany 5 99 1.0× 42 0.7× 23 0.5× 30 0.7× 53 2.2× 5 168
Henriette W Berenschot Netherlands 6 126 1.2× 103 1.8× 62 1.4× 20 0.5× 16 0.7× 11 164
Matthias Hänel Germany 6 109 1.0× 59 1.0× 78 1.8× 82 1.9× 16 0.7× 8 189
Lauren Saguilig United States 7 69 0.7× 63 1.1× 19 0.4× 44 1.0× 32 1.3× 14 161

Countries citing papers authored by Joel Wight

Since Specialization
Citations

This map shows the geographic impact of Joel Wight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Wight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Wight more than expected).

Fields of papers citing papers by Joel Wight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Wight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Wight. The network helps show where Joel Wight may publish in the future.

Co-authorship network of co-authors of Joel Wight

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Wight. A scholar is included among the top collaborators of Joel Wight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Wight. Joel Wight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wight, Joel, et al.. (2025). Low flow: Selecting a limited flow cytometry panel where resources are constrained. Blood Reviews. 72. 101284–101284. 2 indexed citations
2.
Churilov, Leonid, Andrew Grigg, Joel Wight, et al.. (2024). Infection risk and antimicrobial prophylaxis in bendamustine‐treated patients with indolent non‐Hodgkin lymphoma: An Australasian Lymphoma Alliance study. British Journal of Haematology. 205(1). 146–157. 3 indexed citations
3.
4.
5.
Chong, Geoffrey, Colm Keane, Sze-Ting Lee, et al.. (2023). Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. Leukemia. 37(5). 1092–1102. 11 indexed citations
6.
Haider, Ali S., et al.. (2022). Case of the disappearing drusen. Canadian Journal of Ophthalmology. 58(2). e71–e72. 1 indexed citations
7.
Wight, Joel, Matthew Ku, Daniel Carradice, et al.. (2022). Toxicity associated with high-dose intravenous methotrexate for hematological malignancies. Leukemia & lymphoma. 63(10). 2375–2382. 9 indexed citations
8.
Wight, Joel, Nada Hamad, Belinda A. Campbell, et al.. (2021). Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 52(9). 1609–1623. 3 indexed citations
9.
Wight, Joel, Edward Shen, Sze Ting Lee, et al.. (2021). Predicting primary treatment failure using interim FDG‐PET scanning in diffuse large B‐cell lymphoma. European Journal Of Haematology. 107(4). 475–483. 5 indexed citations
10.
Blombery, Piers, Lucy C. Fox, Georgina L. Ryland, et al.. (2020). Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes. Haematologica. 106(1). 64–73. 11 indexed citations
11.
Hawkes, Eliza A., Geoffrey Chong, Charmaine Smith, et al.. (2020). Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study. Blood. 136(Supplement 1). 43–44. 10 indexed citations
12.
13.
14.
Hawkes, Eliza A., Charmaine Smith, Leonid Churilov, et al.. (2019). AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 134(Supplement_1). 5332–5332. 2 indexed citations
15.
Urbancic, Karen, et al.. (2018). Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. Transplant Infectious Disease. 20(6). e12968–e12968. 8 indexed citations
16.
Schwarer, Anthony P., Jason Butler, Kathryn Jackson, et al.. (2018). A Comparison of High‐Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2(6). e158–e158. 2 indexed citations
17.
Chua, Chong Chyn, et al.. (2018). Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis. Pathology. 50(6). 671–674. 1 indexed citations
18.
Wight, Joel, Geoffrey Chong, Andrew Grigg, & Eliza A. Hawkes. (2018). Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews. 32(5). 400–415. 52 indexed citations
19.
20.
Wight, Joel, et al.. (2015). Screening whole spine magnetic resonance imaging in multiple myeloma. Internal Medicine Journal. 45(7). 762–765. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Ansuinelli Breakdown of academic impact, for papers by Jesse Shustik Breakdown of academic impact, for papers by Yazeed Sawalha Breakdown of academic impact, for papers by Anupkumar George Breakdown of academic impact, for papers by Susana Ben Neriah Breakdown of academic impact, for papers by Agnieszka Giza Breakdown of academic impact, for papers by Kerstin Busch Breakdown of academic impact, for papers by Henriette W Berenschot Breakdown of academic impact, for papers by Matthias Hänel Breakdown of academic impact, for papers by Lauren Saguilig
Rankless by CCL
2026